Randy Ban Biography and Net Worth

Randall A. Ban serves as Chief Commercial Officer of the Company. Prior to that, he served as our Senior Vice President, Sales and Marketing from July 2009 to December 2018 and, in December 2018, his title was changed to Senior Vice President, Global Sales and Marketing. Before joining us, he served as Chief Operating Officer at Vertebral Technologies Inc., a medical device company, from 2008 to 2009. From 2006 to 2008, Mr. Ban served as Vice President of Global Marketing, CRM at Boston Scientific. Mr. Ban holds a B.S. in marketing and an M.B.A., both from Indiana University.

What is Randy Ban's net worth?: The estimated net worth of Randy Ban is at least $1.20 million as of February 13th, 2025. Mr. Ban owns 7,259 shares of Inspire Medical Systems stock worth more than $1,200,493 as of March 25th. This net worth approximation does not reflect any other investments that Mr. Ban may own. Learn More about Randy Ban's net worth.
How do I contact Randy Ban?: The corporate mailing address for Mr. Ban and other Inspire Medical Systems executives is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. Inspire Medical Systems can also be reached via phone at (844) 672-4357 and via email at inspire@lifesciadvisors.com. Learn More on Randy Ban's contact information.
Has Randy Ban been buying or selling shares of Inspire Medical Systems?: During the past quarter, Randy Ban has sold $4,694,664.00 of Inspire Medical Systems stock. Most recently, Randy Ban sold 25,584 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $183.50, for a transaction totalling $4,694,664.00. Following the completion of the sale, the insider now directly owns 7,259 shares of the company's stock, valued at $1,332,026.50. Learn More on Randy Ban's trading history.
Who are Inspire Medical Systems' active insiders?: Inspire Medical Systems' insider roster includes Randy Ban (Insider), Richard Buchholz (CFO), Philip Ebeling (COO), Jerry Griffin (Director), Timothy Herbert (CEO), Steven Jandrich (VP), Chau Khuong (Director), Georgia Melenikiotou (Director), Marilyn Nelson (Director), John Rondoni (CTO), and Casey Tansey (Director). Learn More on Inspire Medical Systems' active insiders.
Are insiders buying or selling shares of Inspire Medical Systems?: In the last year, insiders at the sold shares 10 times. They sold a total of 87,503 shares worth more than $17,676,220.64. The most recent insider tranaction occured on February, 13th when insider Randy Ban sold 25,584 shares worth more than $4,694,664.00. Insiders at Inspire Medical Systems own 4.1% of the company. Learn More about insider trades at Inspire Medical Systems.
Information on this page was last updated on 2/13/2025.

Randy Ban Insider Trading History at Inspire Medical Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2025	Sell	25,584	$183.50	$4,694,664.00	7,259
8/16/2024	Sell	4,861	$188.55	$916,541.55	3,056
2/27/2024	Sell	3,060	$182.01	$556,950.60	3,029
2/23/2024	Sell	12,230	$185.37	$2,267,075.10	3,029
1/3/2023	Sell	10,000	$252.10	$2,521,000.00	304
1/5/2022	Sell	3,532	$244.67	$864,174.44
12/27/2021	Sell	1,418	$240.00	$340,320.00
12/23/2021	Sell	8,342	$240.00	$2,002,080.00
1/4/2021	Sell	30,187	$182.15	$5,498,562.05
9/9/2020	Sell	30,000	$117.54	$3,526,200.00
4/9/2020	Sell	10,000	$64.00	$640,000.00
3/4/2020	Sell	10,000	$86.55	$865,500.00	10,000
2/4/2020	Sell	10,000	$76.21	$762,100.00	700
11/18/2019	Sell	6,390	$65.79	$420,398.10
10/29/2019	Sell	19,300	$59.16	$1,141,788.00
9/12/2019	Sell	10,000	$61.62	$616,200.00
6/4/2019	Sell	10,000	$55.39	$553,900.00
5/3/2019	Sell	10,074	$50.09	$504,606.66
4/5/2019	Sell	10,000	$51.70	$517,000.00
4/2/2019	Sell	10,000	$51.51	$515,100.00
1/15/2019	Sell	10,000	$48.59	$485,900.00
11/20/2018	Sell	10,000	$40.37	$403,700.00
5/7/2018	Buy	900	$16.00	$14,400.00

See Full Table

Randy Ban Buying and Selling Activity at Inspire Medical Systems

Inspire Medical Systems Company Overview

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Today's Range

Now: $165.38

$162.35

$172.95

50 Day Range

MA: $180.09

$158.65

$197.49

2 Week Range

Now: $165.38

$123.00

$257.40

Volume

450,146 shs

Average Volume

580,736 shs

Market Capitalization

$4.92 billion

P/E Ratio

95.60

Dividend Yield

N/A

Beta

1.48